<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/87D01A4B-04C9-42BB-9965-215579AF50E1"><gtr:id>87D01A4B-04C9-42BB-9965-215579AF50E1</gtr:id><gtr:name>National Institutes of Health Clinical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/87D01A4B-04C9-42BB-9965-215579AF50E1"><gtr:id>87D01A4B-04C9-42BB-9965-215579AF50E1</gtr:id><gtr:name>National Institutes of Health Clinical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F7153DA4-D553-4E4F-A987-34E7EE2194C3"><gtr:id>F7153DA4-D553-4E4F-A987-34E7EE2194C3</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:surname>Porcher</gtr:surname><gtr:orcidId>0000-0002-9015-5203</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12009%2F9"><gtr:id>A5BB1F6F-039D-4716-8E35-EFEAA39306B0</gtr:id><gtr:title>Transcriptional control of haematopoietic specification and differentiation</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12009/9</gtr:grantReference><gtr:abstractText>Our interests focus on the mechanisms that underlie blood formation and differentiation into mature blood cells (such as those fighting infection, involved in coagulation or in oxygen transport). Many inherited and acquired diseases are associated with anaemia and leukaemia in which production of certain types of blood cells is disrupted. Understanding these disorders depends on knowing how blood normally forms in the bone marrow and throughout development.
Recently, there has been considerable accumulation of knowledge about the factors that direct formation of the blood. One such factor (called SCL, Stem Cell Leukaemia) plays several critical roles in this process. We plan to understand how this factor controls the formation of blood at a molecular level. 
Our main experimental model makes use of mouse embryonic stem (mES) cells that can reproduce the early steps of embryonic development in vitro (in a culture dish). 
We aim at understanding how a blood-specific protein complex forms, how it regulates the coordinated expression of the critical players involved in this pathway and how, when it is deregulated, it may lead to leukaemia and anaemia.</gtr:abstractText><gtr:technicalSummary>Understanding how stem cells are specified during embryonic development and how lineages differentiate to produce mature and specialised cells are central questions in biology and are of crucial interest to elucidate pathways involved in diseases. 
The main aim of this programme is to characterise some of the molecular mechanisms engaged by key regulators of blood development (such as SCL/Tal1), with a particular focus on the early stages of mesoderm patterning and haematopoietic specification. 
Functional identification of protein complexes and their nuclear targets combined with molecular characterisation of their mechanisms of action and structural biology approaches will give insights into genetic interactions and transcriptional networks critical in decision pathways. Using in vitro differentiation of mouse ES cells, mouse haematopoiesis and Xenopus embryos as experimental models, we will start building networks of genetic interactions at the heart of haematopoietic development. 
These approaches are instrumental for our understanding of how a haematopoietic stem cell-specific protein complex might form and how, when this process is deregulated, this leads to leukaemia. Moreover, this might help characterise the pathways leading to definitive haematopoiesis and HSCs from hES and iPS cells that remain poorly characterised. This is important if one wants to be able to produce HSCs in vitro for regenerative medicine purposes.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2264000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Role of Gata1s in fetal megakaryopoiesis</gtr:description><gtr:id>774F3878-F4CB-4280-9E5E-683E0F2AB0FD</gtr:id><gtr:impact>No outputs yet.</gtr:impact><gtr:outcomeId>58bfde3fdeb0a0.80952235-1</gtr:outcomeId><gtr:partnerContribution>Expertise in megakaryopoiesis and function of GATA1 in hematopoiesis</gtr:partnerContribution><gtr:piContribution>Co-supervision of a post-doctoral scientist. Bringing expertise in Cellular and Molecular Biology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Molecular Haematology Unit</gtr:department><gtr:description>GATA1 transcriptional regulation</gtr:description><gtr:id>492CC1CE-3B73-42CC-9E77-A203D702ADE9</gtr:id><gtr:impact>PMID: 20154211
PMID: 18625887
PMID: 16551635</gtr:impact><gtr:outcomeId>LzyvzfwdqDY-1</gtr:outcomeId><gtr:partnerContribution>Expertise in specific technologies</gtr:partnerContribution><gtr:piContribution>Expertise in technologies</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health Clinical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Relationship between arterial and hematopoietic differentiation</gtr:description><gtr:id>4CBBDC91-BF7C-476B-865D-BDFB5F98B7EA</gtr:id><gtr:impact>PMID: 27250641</gtr:impact><gtr:outcomeId>58bfdf561dd577.78507403-1</gtr:outcomeId><gtr:partnerContribution>Expertise in vasculogenesis</gtr:partnerContribution><gtr:piContribution>Initiated the project. Expertise in ES cell differentiation, hematopoietic development.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>Crystal structure</gtr:description><gtr:id>B7B5D796-9335-4A56-A36F-BDDBDCB93086</gtr:id><gtr:impact>PMID: 21076045
PMID: 21045296
PMID: 23831025
The structure has provided us with a structural explanation for how this complex operates. This has important implications for our understanding of the transcriptional regulation of haematopoiesis and leukaemogenesis.</gtr:impact><gtr:outcomeId>H3WWL5uJiXR-1</gtr:outcomeId><gtr:partnerContribution>They have solved the crystal structure of the transcription factor SCL and its partners. We are now further studying this structure in functional assays.</gtr:partnerContribution><gtr:piContribution>We have provided them with a very interesting protein complex to study by X-ray crystallography.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HSC production from ES cells</gtr:description><gtr:id>AA70BC85-5DF2-4CD4-982E-F352229FD8F0</gtr:id><gtr:impact>We have redefined ES cell-derived haematopoiesis and are now in a better position to produce blood stem cells in vitro. If successful, we will be closer to making blood stem cells from patient's own cells. This is however a long-term project.</gtr:impact><gtr:outcomeId>567947bfca75f0.96568109-1</gtr:outcomeId><gtr:partnerContribution>Expertise in haematopoietic development and the human ES/iPS model.</gtr:partnerContribution><gtr:piContribution>Expertise in mouse ES cell cultures and differentiation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health Clinical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HSC production from ES cells</gtr:description><gtr:id>C2C2D2BF-C244-4B43-965D-FFD250BF7573</gtr:id><gtr:impact>We have redefined ES cell-derived haematopoiesis and are now in a better position to produce blood stem cells in vitro. If successful, we will be closer to making blood stem cells from patient's own cells. This is however a long-term project.</gtr:impact><gtr:outcomeId>567947bfca75f0.96568109-2</gtr:outcomeId><gtr:partnerContribution>Expertise in haematopoietic development and the human ES/iPS model.</gtr:partnerContribution><gtr:piContribution>Expertise in mouse ES cell cultures and differentiation</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Molecular Haematology Unit</gtr:department><gtr:description>Function of ETO2 in haematopoietic development</gtr:description><gtr:id>073C1413-18AC-4C06-95F6-DBC8792AF3CB</gtr:id><gtr:impact>PMID: 23318133</gtr:impact><gtr:outcomeId>fiLm9cVUGEd-1</gtr:outcomeId><gtr:partnerContribution>The collaborative lab provided us with expertise, advice and reagents to develop this new project</gtr:partnerContribution><gtr:piContribution>My PhD student collaborated with the partner lab to develop a new project based on findings that stemmed from previous studies in our lab.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6C299E67-23B2-4CBD-9B9E-9CB28A1354CE</gtr:id><gtr:impact>100 pupils attended the talks on biomedical careers. This has inspired pupils to study biology at University.

5th and 6th form pupils came to the lab for work experience</gtr:impact><gtr:outcomeId>rtTFC6zJfvR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WIMM Public lectures</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7CA01A11-A539-4AD6-A461-5FE9B2EB4032</gtr:id><gtr:impact>Mixture of school pupils and people with an interest in science. All the talks were very well perceived and prompted discussions afterwards.

Below is the letter sent by the Head of Science of one of the schools whose pupils attended the lectures:


&amp;quot;Thank you for an excellent evening of lectures last Wednesday. Our boys were very pleased to be there. The talks were pitched at exactly their level and addressed a range of current topics that particularly interest them. Our discussions continued over a meal afterwards in a local restaurant. They had been inspired and stimulated beyond the confines of the A-level syllabus.
 
Thank you to all who made the evening so successful.

 Yours sincerely&amp;quot;,</gtr:impact><gtr:outcomeId>Zwy82zxzsv8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop (can we have it all?)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5FE968E9-13C5-41DF-B587-989EE237010B</gtr:id><gtr:impact>Discussions on common issues experienced by women in science

Decisions made on actions to implement within our Institute to improve women's assertiveness</gtr:impact><gtr:outcomeId>5461e7fdd90b24.42749408</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (MCS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F64B3C81-C155-484A-840C-AFC1D9373CF4</gtr:id><gtr:impact>The talk inspired discussions and reflection on biomedical/science-related careers.

The talk motivated students to embark on scientific studies. Some came to my lab for work experience the following summer.</gtr:impact><gtr:outcomeId>5461e1a0485c54.95476333</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (MCS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E98202DC-33EA-4CDB-BE26-4B61FEE708D7</gtr:id><gtr:impact>The talk inspired discussions and reflection on biomedical/science-related careers.

Following the talk, I had request from pupils wanting to do work experience in my lab. We hosted 4 of those in the summer.</gtr:impact><gtr:outcomeId>56795456663466.77822165</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (MCS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6E084189-00DE-46E8-944B-907D2B78ACAA</gtr:id><gtr:impact>50 pupils attended the career talk who engaged in discussions about science-related careers after the presentation.

6th form students came for a one week lab experience in Summer 2013</gtr:impact><gtr:outcomeId>YN7zovnEQ1y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Women in science meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0E9788DD-FAEB-45DA-973F-7F53630DC47F</gtr:id><gtr:impact>The talk stimulated discussions and increased interactions between women in our Institute

Organisation of specific workshops</gtr:impact><gtr:outcomeId>5461e8c3d66aa7.17127766</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Young PI programme (how to manage people)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CD622E5A-6832-4904-A4AC-7BDB2EF33AD2</gtr:id><gtr:impact>Researchers came to me after the presentation to further discuss specific aspects of my talk.

Better of understanding of what it takes to manage people as a PI.</gtr:impact><gtr:outcomeId>5461e6a53bcd48.22392516</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>B702E7DF-1908-43E4-A6E6-1D6F1F249C12</gtr:id><gtr:outcomeId>fNxqvQ3wJmp</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2020-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>5D0ED3BE-391B-466D-9C7F-2C0B09107B09</gtr:id><gtr:outcomeId>58bfe1e9508ca5.49647919</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>343000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Responsive mode Research Grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>420544AE-C4FF-482E-BF07-BF96EEF123E5</gtr:id><gtr:outcomeId>58bfe1991ad0c6.21393487</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>RNA-seq, ChIP-seq, ATAC-seq databases from blood-fated mesodermal cells</gtr:description><gtr:id>2850BFAA-0875-4C2F-BCFB-AC9E6C30A4AC</gtr:id><gtr:impact>This has provided new insight into the molecular mechanisms underlying lineage specification and highlighted the functional importance of repression mechanisms. More specifically, how a tissue-specific regulator activates a lineage-specific gene expression programme and represses alternative fates in the same cell. This is an important concept likely to apply to other cellular systems.</gtr:impact><gtr:outcomeId>58bfeae281c7a5.46549642</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Whole genome sequencing databases (Flk1+ cells)</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Proteomics database of SCL partners in blood-fated mesodermal cells.</gtr:description><gtr:id>D7F315DA-A612-4379-94B5-C7C7BCBD48C0</gtr:id><gtr:impact>This is contributing to our understanding of the molecular mechanisms underlying lineage specification. More specifically, how a tissue-specific regulator activates a lineage-specific gene expression programme and represses alternative fates in the same cell. This is an important concept likely to apply to other cellular systems.</gtr:impact><gtr:outcomeId>58bfedf9745281.99955736</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Proteomics in Flk1+ cells</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Insertion of the mCherry reporter gene into the Scl locus in mouse ES cells</gtr:description><gtr:id>F458E10A-A418-4299-9DC2-166C122D7BF3</gtr:id><gtr:impact>We can now follow the cellular fate of Scl-null cells. This has allowed to report a cell fate change from blood to cardiac/paraxial lineages in absence of this transcriptional regulator. This is a critical finding for our mechanistic understanding of lineage specification.</gtr:impact><gtr:outcomeId>58bfe88c4a18b5.98232427</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Scl:mCherry ES cell line</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The atomic structure of a key quaternary protein complex bound to DNA was solved by X-ray crystallography</gtr:description><gtr:id>5B039381-6FEF-401A-B517-5C9108E684D9</gtr:id><gtr:impact>Better understanding of some of the molecular mechanisms involved in the transcriptional regulation of haematopoiesis and leukaemogenesis. These observations will apply to other tissue-specific transcriptional complexes.</gtr:impact><gtr:outcomeId>cAvXDyierjx</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>X-ray structure of a quaternary protein complex bound to DNA</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Crystal structure of a complex of two transcriptional regulators involved in many critical developmental and differentiation pathways.</gtr:description><gtr:id>6AC3277D-D156-46C9-8F8F-E0A866CF14D3</gtr:id><gtr:impact>A better understanding of the mechanism of action of a key component of a multiprotein complex. This has increased our knowledge on how multiprotein complexes form.</gtr:impact><gtr:outcomeId>CNWLnEEk5r1</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>X-ray structure of LMO2-LDB1(LID)</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Generation of a new mouse megakaryocytic cell line</gtr:description><gtr:id>7AA31609-11CC-42B1-A809-D257CCF68974</gtr:id><gtr:impact>Very good alternative to using primary mouse mekagaryocyte progenitors.</gtr:impact><gtr:outcomeId>Xz8HkrqAX3Q</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MKD1 cell line</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>688B1A8A-1C83-48A3-A26A-9D46F28E89DA</gtr:id><gtr:title>An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference.</gtr:title><gtr:parentPublicationTitle>Experimental hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83eaa97aba73c726e5a7cf1d92e9ab36"><gtr:id>83eaa97aba73c726e5a7cf1d92e9ab36</gtr:id><gtr:otherNames>Blobel GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0301-472X</gtr:issn><gtr:outcomeId>567942f4d4a1c7.74048604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28B78EDC-E99A-42B9-B181-999CB777B690</gtr:id><gtr:title>Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a017171bc87b2f6382042a9f9a3a08be"><gtr:id>a017171bc87b2f6382042a9f9a3a08be</gtr:id><gtr:otherNames>El Omari K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_15230_20_23831025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>394877D6-58BF-4238-9521-8C6FC5ADA5FD</gtr:id><gtr:title>Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e0b20cfc0518dfe2421077726527510"><gtr:id>8e0b20cfc0518dfe2421077726527510</gtr:id><gtr:otherNames>Karamitros D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5aa62c41a11df5.60279275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA5ED844-2882-4491-8E2E-F4B7A86D2990</gtr:id><gtr:title>EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f4fca6ab2ca6aad1d5993cd541ad0fc"><gtr:id>7f4fca6ab2ca6aad1d5993cd541ad0fc</gtr:id><gtr:otherNames>Chen II</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58bfda5b0a3543.04047111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00DEEEB1-4B94-47A5-B0F3-EE23CDE94A0D</gtr:id><gtr:title>Uncoupling VEGFA functions in arteriogenesis and hematopoietic stem cell specification.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e3074d3fc43b0c44b68d9cfe2dfd095"><gtr:id>1e3074d3fc43b0c44b68d9cfe2dfd095</gtr:id><gtr:otherNames>Leung A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>pm_15230_20_23318133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2912F2BC-0AF5-433E-8266-37B4EE8235B0</gtr:id><gtr:title>SCL/TAL1: a multifaceted regulator from blood development to disease.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30255e6f4729317b1e876bfc796a0621"><gtr:id>30255e6f4729317b1e876bfc796a0621</gtr:id><gtr:otherNames>Porcher C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>58bfda5baadae9.41411720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF057C82-DD20-4620-BCF6-2AA924542AF7</gtr:id><gtr:title>GATA-1 genome-wide occupancy associates with distinct epigenetic profiles in mouse fetal liver erythropoiesis.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ee635df311f5a7a7206dbb3e8937914"><gtr:id>2ee635df311f5a7a7206dbb3e8937914</gtr:id><gtr:otherNames>Papadopoulos GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_15230_20_23519611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2791C874-39AD-4F15-BA0C-897EB6B04165</gtr:id><gtr:title>Establishment of an ES cell-derived murine megakaryocytic cell line, MKD1, with features of primary megakaryocyte progenitors.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee8a9fd4df9990dde2ff823498869c12"><gtr:id>ee8a9fd4df9990dde2ff823498869c12</gtr:id><gtr:otherNames>Chagraoui H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15230_20_22396803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71EDBB2F-5BC1-4EAD-9896-77BFE93EB1AB</gtr:id><gtr:title>Toward a BETter grasp of acetyl-lysine readers.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30255e6f4729317b1e876bfc796a0621"><gtr:id>30255e6f4729317b1e876bfc796a0621</gtr:id><gtr:otherNames>Porcher C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>567942f4945e74.72504127</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8C10516-1A38-4240-84B6-9D34CB4EB75C</gtr:id><gtr:title>Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70d30a423e81944842cc60515ff69f8c"><gtr:id>70d30a423e81944842cc60515ff69f8c</gtr:id><gtr:otherNames>Quek L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>58bfda5b70e994.62255165</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12009/9</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>